<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:4c7ff23d-4ef8-4f88-98c7-1c11e6f22dad,g:0340b329-b133-4dff-8758-8cd08da83d50,d:61460290acc84fad9b5129d58fc039b6--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>axnx-20220802</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl80L2ZyYWc6MDgxYTgxMGYwYzU2NDgyOThiMDY1ZmNjOGRkNjI3OTIvdGFibGU6MWM3MDU4OTI5OTU4NGUyZTlmOWIwNzZmNzk3YzE3ZTcvdGFibGVyYW5nZToxYzcwNTg5Mjk5NTg0ZTJlOWY5YjA3NmY3OTdjMTdlN18yLTEtMS0xLTQ2NzAy_4b212dd5-bd70-4217-a543-2c2a3ba2b954">false</ix:nonNumeric><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl80L2ZyYWc6MDgxYTgxMGYwYzU2NDgyOThiMDY1ZmNjOGRkNjI3OTIvdGFibGU6MWM3MDU4OTI5OTU4NGUyZTlmOWIwNzZmNzk3YzE3ZTcvdGFibGVyYW5nZToxYzcwNTg5Mjk5NTg0ZTJlOWY5YjA3NmY3OTdjMTdlN18zLTEtMS0xLTQ2NzAy_41165071-d5a9-4c0d-8c73-1302647f7af6">0001603756</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="axnx-20220802.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001603756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-02</xbrli:startDate><xbrli:endDate>2022-08-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i61460290acc84fad9b5129d58fc039b6_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.333%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGV4dHJlZ2lvbjo0ZTc5ZTY3ODk2MDA0NGIzOWYyMDIzOTkzOWFkYmU0YV82NzE3_ffab536e-974f-49b5-b833-7a81ac733ce5">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_________________________________________________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 OR 15(d) of The</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGV4dHJlZ2lvbjo0ZTc5ZTY3ODk2MDA0NGIzOWYyMDIzOTkzOWFkYmU0YV8zNjA_34f1df49-20a7-486b-a986-0a3224596b97">August 2, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:23pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGV4dHJlZ2lvbjo0ZTc5ZTY3ODk2MDA0NGIzOWYyMDIzOTkzOWFkYmU0YV82NzE4_e131a99a-5848-4893-9c46-7f7aca659db4">Axonics, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_________________________________________________________________</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:30.749%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.749%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.752%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6OWU0NzRlOGU4YWRiNGE0YjlhNWJmZDA1Mzg5NzY2ZjEvdGFibGVyYW5nZTo5ZTQ3NGU4ZThhZGI0YTRiOWE1YmZkMDUzODk3NjZmMV8wLTAtMS0xLTQ2NzAy_6a703e9b-f9fc-4680-8d94-c231c8726136">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6OWU0NzRlOGU4YWRiNGE0YjlhNWJmZDA1Mzg5NzY2ZjEvdGFibGVyYW5nZTo5ZTQ3NGU4ZThhZGI0YTRiOWE1YmZkMDUzODk3NjZmMV8wLTItMS0xLTQ2NzAy_3c6e2830-fd5d-4923-b40b-873986efd36a">001-38721</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6OWU0NzRlOGU4YWRiNGE0YjlhNWJmZDA1Mzg5NzY2ZjEvdGFibGVyYW5nZTo5ZTQ3NGU4ZThhZGI0YTRiOWE1YmZkMDUzODk3NjZmMV8wLTQtMS0xLTQ2NzAy_3d7c5861-f75a-4451-a689-224d20cd1aa9">45-4744083</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGV4dHJlZ2lvbjo0ZTc5ZTY3ODk2MDA0NGIzOWYyMDIzOTkzOWFkYmU0YV82NzE5_8b4902dd-5a4b-4580-b5e7-26ef70c1a91f">26 Technology Drive</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGV4dHJlZ2lvbjo0ZTc5ZTY3ODk2MDA0NGIzOWYyMDIzOTkzOWFkYmU0YV82NzIw_0e18b53b-d2cd-4803-908e-94f9c8dbeb18">Irvine</ix:nonNumeric>, <ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGV4dHJlZ2lvbjo0ZTc5ZTY3ODk2MDA0NGIzOWYyMDIzOTkzOWFkYmU0YV82NzIx_6f411c5e-80b2-4593-9a1f-72baee39b0d9">California</ix:nonNumeric> <ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGV4dHJlZ2lvbjo0ZTc5ZTY3ODk2MDA0NGIzOWYyMDIzOTkzOWFkYmU0YV82NzE0_eb26f7ba-28d9-446c-9e5c-b1d2a595b3bd">92618</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGV4dHJlZ2lvbjo0ZTc5ZTY3ODk2MDA0NGIzOWYyMDIzOTkzOWFkYmU0YV82NzE1_d16ee174-c97f-47f5-9d04-b98edc9f64dc">949</ix:nonNumeric>) <ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGV4dHJlZ2lvbjo0ZTc5ZTY3ODk2MDA0NGIzOWYyMDIzOTkzOWFkYmU0YV82NzE2_d0379210-90f8-47b2-8bef-dbdf1db7ba6b">396-6322</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_________________________________________________________________</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6OWExYmNmN2YyMmJkNDhmNTk4YWEzZjFmMjc2NjM1NWQvdGFibGVyYW5nZTo5YTFiY2Y3ZjIyYmQ0OGY1OThhYTNmMWYyNzY2MzU1ZF8wLTEtMS0xLTQ2NzAy_c4329d69-07ba-4c26-b21a-fe3bba812945">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6OTZkN2Q0MTdmOWJmNDNjYmFjYzU0YzUxOGY2ZmU3MTkvdGFibGVyYW5nZTo5NmQ3ZDQxN2Y5YmY0M2NiYWNjNTRjNTE4ZjZmZTcxOV8wLTEtMS0xLTQ2NzAy_1d7aa13e-e797-4a6b-beae-909badaa3dd0">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6ODMxYzhlMjgzNjY1NGU2MWJkZTEyNzI1OTJlMTFjZDUvdGFibGVyYW5nZTo4MzFjOGUyODM2NjU0ZTYxYmRlMTI3MjU5MmUxMWNkNV8wLTEtMS0xLTQ2NzAy_a7bac94f-37e0-4dcc-a7de-0ae8d967d49d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6ODA3M2U0NTczOWY1NDUyOWI5NTc5ZTQzM2ZmZTVmNWQvdGFibGVyYW5nZTo4MDczZTQ1NzM5ZjU0NTI5Yjk1NzllNDMzZmZlNWY1ZF8wLTEtMS0xLTQ2NzAy_2f617402-c4e3-434c-bcca-9f9d49a72d2f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Exchange Act:</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.722%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.612%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.092%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title of class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Trading symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name of exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6ZDg4N2Q1YzQwMDc1NDM3YTljNmQ2NDU1Yjg1YTE0NjgvdGFibGVyYW5nZTpkODg3ZDVjNDAwNzU0MzdhOWM2ZDY0NTViODVhMTQ2OF8xLTAtMS0xLTQ2NzAy_88c035d1-7e1e-4133-8df1-43c8956c0bda">Common stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6ZDg4N2Q1YzQwMDc1NDM3YTljNmQ2NDU1Yjg1YTE0NjgvdGFibGVyYW5nZTpkODg3ZDVjNDAwNzU0MzdhOWM2ZDY0NTViODVhMTQ2OF8xLTEtMS0xLTQ2NzAy_47a6e3dc-677d-435d-bd95-29844133d9f4">AXNX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6ZDg4N2Q1YzQwMDc1NDM3YTljNmQ2NDU1Yjg1YTE0NjgvdGFibGVyYW5nZTpkODg3ZDVjNDAwNzU0MzdhOWM2ZDY0NTViODVhMTQ2OF8xLTItMS0xLTQ2NzAy_6e1bf224-86fa-4dee-ba65-7c06d24e763c">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.138%"><tr><td style="width:1.0%"></td><td style="width:21.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief7ecb7141504a0aa403a3ec749614fe_D20220802-20220802" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjYxNDYwMjkwYWNjODRmYWQ5YjUxMjlkNThmYzAzOWI2L3NlYzo2MTQ2MDI5MGFjYzg0ZmFkOWI1MTI5ZDU4ZmMwMzliNl8xL2ZyYWc6NGU3OWU2Nzg5NjAwNDRiMzlmMjAyMzk5MzlhZGJlNGEvdGFibGU6ZGE2NjU0Mjc1NjYxNDUyNmFmYjQzN2Y0YTMyZThlMmEvdGFibGVyYW5nZTpkYTY2NTQyNzU2NjE0NTI2YWZiNDM3ZjRhMzJlOGUyYV8wLTMtMS0xLTQ2NzAy_568f16ba-6244-49b3-832a-1270b7b03cce">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744; </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.333%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01.&#160;&#160;&#160;&#160;Entry into a Material Definitive Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2022, Axonics, Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with BofA Securities, Inc. (the &#8220;Underwriter&#8221;), relating to an underwritten public offering (the &#8220;Offering&#8221;) of 1,750,000 shares of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;). The Underwriter agreed to purchase the Common Stock pursuant to the Underwriting Agreement at a price of $63.85 per share of Common Stock. Under the terms of the Underwriting Agreement, the Company also granted to the Underwriter an option, exercisable in whole or in part at any time for a period of 30 days from the date of the Underwriting Agreement, to purchase up to an additional 262,500 shares of Common Stock from the Company at a price of $63.85 per share of Common Stock, which option was exercised in full prior to the closing of the Offering. The Offering closed on August 5, 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Offering was made pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-238064) and a related prospectus supplement filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on August 2, 2022. A copy of the legal opinion of K&amp;L Gates LLP relating to the legality of the issuance and sale of the shares of Common Stock in the Offering is filed herewith as Exhibit 5.1 hereto.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds to the Company from the Offering were approximately $128.3 million, including from the exercise by the Underwriter of its option to purchase additional shares as described above, after deducting estimated offering expenses payable by the Company.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriter, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. In addition, subject to certain exceptions, the Company and its executive officers and directors have agreed not to sell or otherwise dispose of any of the shares of Common Stock or securities convertible into or exchangeable or exercisable for any shares of Common Stock held by them for a period ending 30 days after the date of the Underwriting Agreement without first obtaining the written consent of the Underwriter.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the terms of the Underwriting Agreement does not purport to be complete and is subject to, and qualified in its entirety by reference to, the Underwriting Agreement, which is filed herewith as Exhibit 1.1 and is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties. Accordingly, the Underwriting Agreement is incorporated herein by reference only to provide investors with information regarding the terms of the Underwriting Agreement, and not to provide investors with any other factual information regarding the Company or its business, and should be read in conjunction with the disclosures in the Company&#8217;s periodic reports and other filings with the SEC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-Looking Statements</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Current Report on Form 8-K contains forward-looking statements that involve risks and uncertainties. The risks and uncertainties involved include the Company&#8217;s ability to satisfy certain conditions to closing on a timely basis or at all, market conditions, and other risks detailed from time to time in the Company&#8217;s periodic reports and other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements, which are based on the Company&#8217;s current expectations and assumptions and speak only as of the date of this Current Report on Form 8-K. The Company does not intend to revise or update any forward-looking statement in this Current Report on Form 8-K as a result of new information, future events or otherwise, except as required by law.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01.&#160;&#160;&#160;&#160;Other Events.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2022, the Company issued press releases announcing that it had launched and priced the Offering, and on August 5, 2022, the Company issued a press release announcing the closing of the Offering. Copies of the press releases are attached as Exhibits 99.1, 99.2 and 99.3, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Exhibits.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:1pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"></td><td style="width:18.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="axnx-080522xex11.htm">Underwriting Agreement, dated August 2, 2022, by and between Axonics, Inc. and BofA Securities, Inc.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="axnx-080522xex51.htm">Opinion of K&amp;L Gates LLP</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="axnx-080522xex51.htm">Consent of K&amp;L Gates LLP (included in Exhibit 5.1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="axnx-080522xex991.htm">Press Release of Axonics, Inc. dated August 2, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="axnx-080522xex992.htm">Press Release of Axonics, Inc. dated August 2, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="axnx-080522xex993.htm">Press Release of Axonics, Inc. dated August 5, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Date File - the cover page XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.554%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AXONICS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: August 5, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Raymond W. Cohen</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond W. Cohen</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "axnx-20220802.htm", "description": "8-K", "secsgml_size_bytes": 48605}]
{"company-data": {"conformed-name": "Axonics, Inc.", "cik": "0001603756", "assigned-sic": "3841", "irs-number": "454744083", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-38721", "film-number": "221141436"}, "business-address": {"street1": "26 TECHNOLOGY DRIVE", "city": "IRVINE", "state": "CA", "zip": "92618", "phone": "949-396-6322"}, "mail-address": {"street1": "26 TECHNOLOGY DRIVE", "city": "IRVINE", "state": "CA", "zip": "92618"}, "former-company": {"former-conformed-name": "Axonics Modulation Technologies, Inc.", "date-changed": "20140326"}}
axnx-20220802
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________________________
FORM
8-K
_________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 2, 2022
_________________________________________________________________
Axonics, Inc.
(Exact name of registrant as specified in its charter)
_________________________________________________________________
Delaware
001-38721
45-4744083
(State or other jurisdiction
of incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
26 Technology Drive
Irvine
,
California
92618
(Address of principal executive offices) (Zip Code)
(
949
)
396-6322
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
_________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of class
Trading symbol
Name of exchange on which registered
Common stock, par value $0.0001 per share
AXNX
Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Item 1.01.    Entry into a Material Definitive Agreement.
On August 2, 2022, Axonics, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with BofA Securities, Inc. (the "Underwriter"), relating to an underwritten public offering (the "Offering") of 1,750,000 shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"). The Underwriter agreed to purchase the Common Stock pursuant to the Underwriting Agreement at a price of $63.85 per share of Common Stock. Under the terms of the Underwriting Agreement, the Company also granted to the Underwriter an option, exercisable in whole or in part at any time for a period of 30 days from the date of the Underwriting Agreement, to purchase up to an additional 262,500 shares of Common Stock from the Company at a price of $63.85 per share of Common Stock, which option was exercised in full prior to the closing of the Offering. The Offering closed on August 5, 2022.
The Offering was made pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-238064) and a related prospectus supplement filed with the Securities and Exchange Commission (the "SEC") on August 2, 2022. A copy of the legal opinion of K&L Gates LLP relating to the legality of the issuance and sale of the shares of Common Stock in the Offering is filed herewith as Exhibit 5.1 hereto.
The net proceeds to the Company from the Offering were approximately $128.3 million, including from the exercise by the Underwriter of its option to purchase additional shares as described above, after deducting estimated offering expenses payable by the Company.
The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriter, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. In addition, subject to certain exceptions, the Company and its executive officers and directors have agreed not to sell or otherwise dispose of any of the shares of Common Stock or securities convertible into or exchangeable or exercisable for any shares of Common Stock held by them for a period ending 30 days after the date of the Underwriting Agreement without first obtaining the written consent of the Underwriter.
The foregoing description of the terms of the Underwriting Agreement does not purport to be complete and is subject to, and qualified in its entirety by reference to, the Underwriting Agreement, which is filed herewith as Exhibit 1.1 and is incorporated herein by reference.
The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties. Accordingly, the Underwriting Agreement is incorporated herein by reference only to provide investors with information regarding the terms of the Underwriting Agreement, and not to provide investors with any other factual information regarding the Company or its business, and should be read in conjunction with the disclosures in the Company's periodic reports and other filings with the SEC.
Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements that involve risks and uncertainties. The risks and uncertainties involved include the Company's ability to satisfy certain conditions to closing on a timely basis or at all, market conditions, and other risks detailed from time to time in the Company's periodic reports and other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements, which are based on the Company's current expectations and assumptions and speak only as of the date of this Current Report on Form 8-K. The Company does not intend to revise or update any forward-looking statement in this Current Report on Form 8-K as a result of new information, future events or otherwise, except as required by law.
Item 8.01.    Other Events.
On August 2, 2022, the Company issued press releases announcing that it had launched and priced the Offering, and on August 5, 2022, the Company issued a press release announcing the closing of the Offering. Copies of the press releases are attached as Exhibits 99.1, 99.2 and 99.3, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.
Item 9.01.    Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
1.1
Underwriting Agreement, dated August 2, 2022, by and between Axonics, Inc. and BofA Securities, Inc.
5.1
Opinion of K&L Gates LLP
23.1
Consent of K&L Gates LLP (included in Exhibit 5.1)
99.1
Press Release of Axonics, Inc. dated August 2, 2022
99.2
Press Release of Axonics, Inc. dated August 2, 2022
99.3
Press Release of Axonics, Inc. dated August 5, 2022
104
Cover Page Interactive Date File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AXONICS, INC.
Dated: August 5, 2022
By:
/s/ Raymond W. Cohen
Raymond W. Cohen
Chief Executive Officer